World News: 16:15 GMT Monday 5th February 2018. [Nymox Pharmaceutical Corporation via Globe Newswire via SPi World News]
HASBROUCK HEIGHTS NJ Feb 05 2018 GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation NASDAQNYMX announced today that the Company will submit a New Drug Application NDA for Fexapotide Triflutate for the treatment of BPH in the US The C ompany ...
Globe Newswire: 16:15 GMT Monday 5th February 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.